Prime Medicine Inc. (PRME)
Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
3. 13
-0.09
-2.795%
$
626.74M Market Cap
- P/E Ratio
- Div Yield
3.35M Volume
-1.83 Eps
$ 3.22
Previous Close 
Want to track PRME and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Prime Medicine (PRME) Stock: Buy or Sell Before Q2 Earnings?
While Prime Medicine's (PRME) pipeline progress is encouraging, the precarious cash position is worrisome. We advise a wait-and-watch approach before Q2 results.
Zacks | 1 year ago
Prime Medicine (PRME) Gains 16.4% in 3 Months: Buy Now or Wait?
While Prime Medicine (PRME) exhibits potential with its encouraging pipeline progress, the current cash position warrants caution. We advise a wait-and-watch approach at current levels.
Zacks | 2 years ago
Wall Street Analysts Believe Prime Medicine, Inc. (PRME) Could Rally 120.95%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 121% in Prime Medicine, Inc. (PRME). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks | 2 years ago
